Nykode | Sustainability Performance
Engaged in biopharmaceutical research, this company specializes in the development of therapeutic vaccines. Its operations emphasize innovative approaches to address unmet medical needs within the healthcare sector.
1923
Norway
5,001 - 10,000 employees
Biotechnology
$500K - 1M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3927
Overallⓘ#96
in Norwayⓘ#60
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissions
Controversy level
- Nykode reported significant R&D spending with no commercial revenue, raising questions about cash runway and financing needs.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.